Exenatide and Renal Outcomes in Patients with Type 2 Diabetes and Diabetic Kidney Disease

Conclusion: Exenatide plus insulin glargine treatment for 24 weeks resulted in a reduction of albuminuria in T2DM patients with DKD.Am J Nephrol
Source: American Journal of Nephrology - Category: Neurology Source Type: research